- Home
- INZY vs MYFW Comparison
INZY vs MYFW Comparison
Compare INZY & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- MYFW
- Stock Information
- Founded
- INZY 2015
- MYFW 2002
- Country
- INZY United States
- MYFW United States
- Employees
- INZY N/A
- MYFW N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- MYFW Major Banks
- Sector
- INZY Health Care
- MYFW Finance
- Exchange
- INZY Nasdaq
- MYFW Nasdaq
- Market Cap
- INZY 188.2M
- MYFW 170.9M
- IPO Year
- INZY 2020
- MYFW 2018
- Fundamental
- Price
- INZY $1.42
- MYFW $21.06
- Analyst Decision
- INZY Strong Buy
- MYFW Buy
- Analyst Count
- INZY 8
- MYFW 3
- Target Price
- INZY $17.75
- MYFW $21.83
- AVG Volume (30 Days)
- INZY 1.0M
- MYFW 29.5K
- Earning Date
- INZY 03-11-2025
- MYFW 01-23-2025
- Dividend Yield
- INZY N/A
- MYFW N/A
- EPS Growth
- INZY N/A
- MYFW N/A
- EPS
- INZY N/A
- MYFW 0.26
- Revenue
- INZY N/A
- MYFW $79,649,000.00
- Revenue This Year
- INZY N/A
- MYFW N/A
- Revenue Next Year
- INZY N/A
- MYFW $12.86
- P/E Ratio
- INZY N/A
- MYFW $81.36
- Revenue Growth
- INZY N/A
- MYFW N/A
- 52 Week Low
- INZY $1.24
- MYFW $12.84
- 52 Week High
- INZY $7.80
- MYFW $22.32
- Technical
- Relative Strength Index (RSI)
- INZY 31.52
- MYFW 63.82
- Support Level
- INZY $1.35
- MYFW $19.50
- Resistance Level
- INZY $1.45
- MYFW $21.27
- Average True Range (ATR)
- INZY 0.12
- MYFW 0.81
- MACD
- INZY 0.04
- MYFW 0.33
- Stochastic Oscillator
- INZY 43.42
- MYFW 99.47
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.